Dylan is the Founder & CEO of Mindbloom, an NYC-based mental health and wellbeing startup helping people expand their human potential with clinician-prescribed, guided psychedelic medicine experiences. There, he is partnering with clinicians, technologists, researchers, and patients to increase access to science-backed treatments, starting by reducing the cost of ketamine therapy for depression and anxiety by over 65%.


Dylan is a 10-year psychedelic medicine patient and 3-time tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton School at The University of Pennsylvania.


____________________


SHOW NOTES


1:08 - My background with anxiety and being a Mindbloom patient


9:27 - Background on Mindbloom


11:50 - Dylan's personal experience with psychedelics


16:47 - How Mindbloom is making ketamine accessible with telemedicine


22:36 - The different ways to take ketamine


24:46 - Ketamine dosing


27:20 - What a Mindbloom experience is like


31:23 - The importance of focus when building a startup


36:27 - Should psychedelics be legal


39:28 - How Dylan is building company culture at Mindbloom


Full Show Notes, Transcript and YouTube Clips can be found at www.mindthings.co/dylan-beynon/


____________________


LINKS


https://www.mindbloom.co/


____________________


MIND THINGS


Follow us on Twitter: @mindthingsco


Subscribe to our newsletter


Follow us on YouTube

Twitter Mentions